GEN - Leslie Lyons (HUGEN ‘91, '87), professor of comparative medicine at the College of Veterinary Medicine, University of Missouri, emphasizes the importance of using the right model for studying a disease. When one thinks of the most popular and useful animal models in biomedical research, one thinks of mice and rats, followed by rabbits, dogs, monkeys, and so on.
PENN LIVE - "We have found [monoclonal antibody treatments] to be remarkably safe and remarkably effective," said HPM faculty Derek Angus (BCHS '92) who is also the Mitchell P. Fink Endowed Chair of Critical Care Medicine at Pitt Medicine. UPMC is also involved in a global trial, known as REMAP, which uses a relatively new method of clinical trials to test new treatments. Angus said that the REMAP trial "helped settle the debate that hydroxychlo...
PITTSBURGH POST-GAZETTE - An op-ed from Mary Ganguli (EPI '87): Imagine that your doctor has just told that you most likely have Alzheimer’s disease, an incurable type of dementia. And then you see on the news that the U.S. Food and Drug Administration (FDA) has approved a new drug for Alzheimer’s disease called aducanumab, made by a company called Biogen. But, you also read, many doctors oppose the FDA decision. Why would anyone oppose a drug f...
KDKA RADIO - On the topic of the recently-released information on boosters for mRNA vaccines for COVID-19, David Nace (EPI '95), chief medical officer for UPMC Senior Communities pointed out that this wasn't a shock. "There's been a lot of data from these vaccines, but also from our prior experience with other vaccines, like the flu vaccine. We know that there tends to be a drop off, not with all but some tend to have a decline in the response o...
WITF - The research shows promise, but the success of treating obesity by targeting these genes is not guaranteed, according to HUGEN's Ryan Minster (HUGEN '11). "That's because the human body itself is extremely resistant to losing weight," Minster said. "Beyond that, most of us live in social, physical and occupational environments that foster weight gain."
THE SCIENTIST - In 2019, Kathyayini Gopalakrishna (HUGEN '20) and colleagues deomonstrated the importance of bacteria-specific IgA antibodies in preventing overexpansion of Enterobacteriaceae—a classic hallmark of NEC—in the guts of preterm babies. These and other results imply that immune education in the final weeks before birth is important for babies' immune systems to tolerate friendly bacteria.
BCHS' Sara Baumann is a mixed-methods researcher harnessing participatory, arts-based tools to study mental health and reproductive health issues. She was living in Nepal in 2015 when a 7.9 magnitude earthquake struck, killing close to 9,000 people and displacing half a million. Watch the recording, where Sara talks about the community art that rose from the aftermath of the tragic and traumatic event.
PITTSBURGH POST-GAZETTE - "I'm hopeful that this will help to start improving the vaccine uptake among employees in the long-term care workforce, because we really need to get those numbers up," said David Nace (EPI '95), chief medical officer of UPMC Senior Communities and an expert in long-term care and flu programs.
HPP DEBATED - BCHS' Sara Baumann (BCHS '19) talks about a recent article in the journal Health Policy and Planning, Is criminalization the answer? Perspectives of community members and police on menstrual seclusion policy in Far-West Nepal. The study was completed by an interdisiplinary Pitt team including Baumann, BCHS's Jessie Burke, and BCHS students Monica Merante, Chris Wiltrout, and Trevor Cutlip.
PITTWIRE - Among the latest to be added to Pitt's Board of Trustees is alumna Hui (Debra) Cen (IDM '91). Cen is a biologist, biotech entrepreneur, Rotarian and social entrepreneur who did biomedical research at the National Institutes of Health, the University of California, San Francisco and Chiron. Her latest initiative is a program to match successful Chinese immigrant volunteers and mentors with educational and financial literacy programs se...